The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Overexpression of Osteopontin Is Associated with More Aggressive Phenotypes in Human Non–Small Cell Lung Cancer
Abstract
Purpose: The extracellular matrix (ECM) molecule osteopontin is implicated in many pathologic processes, including inflammation, cell proliferation, ECM invasion, tumor progression, and metastasis. The present study evaluated the clinical and biological importance of osteopontin in human lung cancer. Experimental Design and Results: Tissue microarrays derived from non–small cell lung cancer (NSCLC) patients were analyzed immunohistochemically. Osteopontin protein expression was observed in 64.5% (205 of 318) of primary tumors and 75.5% (108 of 143) of lymph node metastases, but in only 27.9% (12 of 43) of normal-appearing bronchial epithelial and pulmonary tissues. Osteopontin expression was associated with tumor growth, tumor staging, and lymph node invasion. In vitro osteopontin enhanced ECM invasion of NSCLC cells, and an osteopontin antibody abolished this effect. We further analyzed osteopontin levels in circulating plasma derived from 158 patients with NSCLC, 54 patients of benign pulmonary disease, and 25 healthy donors, and found that the median osteopontin levels for the three groups were 319.1, 161.6, and 17.9 ng/mL, respectively. Conclusions: Overexpression of osteopontin is common in primary NSCLC and may be important in the development and progression of the cancer. Osteopontin levels in the plasma may serve as a biomarker for diagnosing or monitoring patients with NSCLC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Cited by
Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer
Bellahcène, A., Castronovo, V., Ogbureke, K. U. E., Fisher, L. W., & Fedarko, N. S. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2345 · Cited by 454
Zhang, Y., Du, W., Chen, Z., & Xiang, C. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.08.028 · Cited by 299
Wang, R., Wang, Z.-X., Yang, J.-S., Pan, X., De, W., & Chen, L.-B. (2011) · Oncogene · doi:10.1038/onc.2010.642 · Cited by 297
Le, Q.-T., Chen, E., Salim, A., Cao, H., Kong, C. S., Whyte, R., Donington, J., Cannon, W., Wakelee, H., Tibshirani, R., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2049 · Cited by 290
The Role of Osteopontin in Respiratory Health and Disease
Barkas, G. I., & Kotsiou, O. S. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13081259 · Cited by 16
Metadata
- Authors
- Hu, Z., Lin, D., Yuan, J., Xiao, T., Zhang, H., Sun, W., Han, N., Ma, Y., Di, X., Gao, M., Ma, J., Zhang, J., Cheng, S., & Gao, Y.
- Venue
- Clinical Cancer Research
- Published
- 2005-07-01
- Volume
- 11
- Issue
- 13
- Pages
- 4646-4652
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W2112056046
- Cited by
- 167
- References
- 1
- FWCI
- 4.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Overexpression of Osteopontin Is Associated with More Aggressive Phenotypes in Human Non–Small Cell Lung Cancer. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-04-2013
- The paper
- Hu, Z., Lin, D., Yuan, J., Xiao, T., Zhang, H., Sun, W., Han, N., Ma, Y., Di, X., Gao, M., Ma, J., Zhang, J., Cheng, S., & Gao, Y. (2005). Overexpression of Osteopontin Is Associated with More Aggressive Phenotypes in Human Non–Small Cell Lung Cancer. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-04-2013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.